United States pharmaceutical companies are marketing or manufacturing drugs in less developed countries which add hazards to the diseases they are intended to control. For many pharmaceutical companies the financial benefits outweigh any possible risks. In many cases U.S. export laws and other nations' import laws are not enforced and people are denied their right to be provided with full unbiased disclosure of all medications they are considering consenting to.
Get full access to this article
View all access options for this article.
References
1.
EhrenreichB.DowieM. and MinkinS., The Charge: Gynocide the Accused The U.S. Government, Mother Jones, p. 4, November 1979.
2.
U.S. Senate, Committee on Small Business, Present Status of Competition in the Pharmaceutical Industry p. 15397, May 26–27, 1976.
3.
McCraineN. and MurrayM., The Pharmaceutical Industry: A Further Study in Corporate Power, International Journal of Health Services, 8: 4, p. 579, 1978.
4.
JamesB., The Future of the Multinational Pharmaceutical Industry to 1990, Halstead press, p. 28, 1977.
5.
DowieM., The Corporate Crime of the Century, Mother Jones, p. 1, November 1979.
6.
Federal Food Drug and Cosmetic Act, 1/80, p. 138.
7.
Requirements of Laws and Regulations Enforced by the U.S. Food and Drug Administration, U.S. Dept. of Health, Education and Welfare, publication No. 79-1042, p. 64, 1980.
8.
SilvermanM., and LeeP., Pills, Profits, and Politics, University of California Press, pp. 48–80, 1976.
9.
SilvermanM., The Drugging of the Americas, University of California Press, p. 117, 1976.
10.
World Health Organization, Pharmaceuticals in Developing Countries, International Digest of Health Legislation, 31: 3, p. 459, 1980.
11.
Pharmaceutical Manufacturers Association, “The Economic and Social Contributions of the U.S. Multinational Pharmaceutical Industry, p. 10, May 1976.
12.
Pharmaceutical Manufacturers Association, The Pharmaceutical Industry and the Third World, p. 3, August 1979.
13.
National Women's Health Network, Network News Alert on Depo-Provera, p. 1.
14.
HennebergK. and RothschildM., Contraceptive Draws Fire, Multinational Monitor, p. 21, December 1980.
15.
Washington Post, Unsafe in Any Country?, February 27, 1980.
16.
BlackwellA., and SalisburyL., Memorandum from Law Offices of Public Advocates, regarding anti-dumping case, p. 2, July 8, 1980.
17.
RodaleR. and DeCrostaA., An Exported Danger Boomerangs, Los Angeles Times, March 10, 1981.
18.
Pharmaceutical Manufacturers Association, The Pharmaceutical Industry: International Issues and Answers, p. 5, April 1979.
19.
LallS. and BibileS., The Political Economy of Controlling Transnationals: The Pharmaceutical Industry in Sri Lanka, 1 972–76, International Journal of Health Services, 8: 2, p. 303, 1978.
20.
East African Medical Journal, Drug Regulatory Authority in Kenya, p. 448, July, 1980.
21.
U. S. House of Representatives, Committee on Foreign Affairs, “Export of Hazardous Products,” p. 2, June 5, June 12, and September 9, 1980.
